Title: Jack Kavanaugh Former Executive Chairman at ARROGENE, INC
1Jack Kavanaugh
CEO Nanotech Energy Inc
2About Me..
Jack Kavanaugh is one of successful Business
leader and doctor in medical and science
technology companies. He has been a member or
chairman of the board of directors in numerous
science technology companies. Dr. Jack Kavanaugh
was a Board Certified eye surgeon, having done
his residency at UCLAs Jules Stein Institute,
where he was a part time visiting professor until
2008, teaching surgery to residents and fellows.
He has developed and managed companies at every
stage from inception to successful sale.
3- Dr. Jack Kavanaugh began his distinctive career
as a highly successful dentist.
4Dr. Jack Personal Profile
5- Dr. Jack Kavanaughs background as a physician
and a business executive has led to the
development of an unusual skill set.
6Jack Kavanaugh Achievements
- Nanotech Energy Inc.
- Co-founded by Dr. Jack Kavanaugh, has exclusively
licensed from UCLA leading super battery and
supercapacitor intellectual property that has
been applied to the development of energy storage
and delivery devices that can store and deliver
energy at significantly higher rates than today's
batteries and can significantly affect the world
of energy storage and delivery.
7SuperMetalix Inc. Co-founded by Dr. Jack
Kavanaugh, has exclusively licensed from UCLA
leading super hard metal intellectual property
which is being applied to development of multiple
applications currently addressed by the 22
billion per year and growing at a 10 annual
compounded rate, carbide industry.
8Novonco Therapeutics Inc. A clinical stage
company, was founded by Dr. Jack Kavanaugh, Dr.
Larry Overman (University of California Irvine)
and Dr. David Horne (City of Hope). Novonco has
developed 3 distinct therapeutics and separate
platforms each having multiple different cancer
targets. Its first platform is already in US FDA
human trials being conducted at City of Hope for
ovarian and breast cancer.
9- ZetaRx Biosciences Inc.
- Dr. Kavanaugh along with two leading oncologists
in 2008 founded ZetaRx Biosciences, Inc. Dr.
Kavanaugh successfully combined exclusive
technological licensing from top health care and
research institutions to place ZetaRx at the
leading edge of immunotherapy for the treatment
of cancer he assembled a well-seasoned team and
guided the clinical strategy.
10THANKS!
11(No Transcript)